DECODE Obesity: Focusing On Mature Assessments Of Physical Activity And Function

Obesity is projected to affect more than half of the world’s population by 2035, and new GLP-1 therapies have led to more than 100 ongoing clinical trials. But weight loss alone tells only part of the story. Physical activity is a cornerstone of weight management, yet it has not been well measured in GLP-1 trials. Concerns about lean muscle loss raise questions about whether losing weight always means better health. Payers also increasingly want proof of benefits beyond the scale.
The DECODE Obesity working group uses wearable digital health technologies to capture objective measures of how people with obesity move, function, and sleep, with little burden on participants. The group is generating clinical evidence in three areas: physical activity as a covariate (a factor that helps put treatment results in context), and physical function and sleep as endpoints. Discover how wearable-based endpoints can help your obesity program show health benefits that matter to patients, regulators, and payers.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.